These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26334777)

  • 21. Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma.
    Gunderson AJ; Yamazaki T; McCarty K; Phillips M; Alice A; Bambina S; Zebertavage L; Friedman D; Cottam B; Newell P; Gough MJ; Crittenden MR; Van der Veken P; Young KH
    PLoS One; 2019; 14(2):e0211117. PubMed ID: 30726287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth.
    Cheng JD; Valianou M; Canutescu AA; Jaffe EK; Lee HO; Wang H; Lai JH; Bachovchin WW; Weiner LM
    Mol Cancer Ther; 2005 Mar; 4(3):351-60. PubMed ID: 15767544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor activity of SS(dsFv)PE38 and SS1(dsFv)PE38, recombinant antimesothelin immunotoxins against human gynecologic cancers grown in organotypic culture in vitro.
    Hassan R; Lerner MR; Benbrook D; Lightfoot SA; Brackett DJ; Wang QC; Pastan I
    Clin Cancer Res; 2002 Nov; 8(11):3520-6. PubMed ID: 12429643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer.
    Tchou J; Zhang PJ; Bi Y; Satija C; Marjumdar R; Stephen TL; Lo A; Chen H; Mies C; June CH; Conejo-Garcia J; Puré E
    Hum Pathol; 2013 Nov; 44(11):2549-57. PubMed ID: 24074532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroblast activation protein-α: a key modulator of the microenvironment in multiple pathologies.
    Kelly T; Huang Y; Simms AE; Mazur A
    Int Rev Cell Mol Biol; 2012; 297():83-116. PubMed ID: 22608558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin.
    LeBeau AM; Brennen WN; Aggarwal S; Denmeade SR
    Mol Cancer Ther; 2009 May; 8(5):1378-86. PubMed ID: 19417147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.
    Santos AM; Jung J; Aziz N; Kissil JL; Puré E
    J Clin Invest; 2009 Dec; 119(12):3613-25. PubMed ID: 19920354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts.
    Welt S; Divgi CR; Scott AM; Garin-Chesa P; Finn RD; Graham M; Carswell EA; Cohen A; Larson SM; Old LJ
    J Clin Oncol; 1994 Jun; 12(6):1193-203. PubMed ID: 8201382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroblast activation protein increases metastatic potential of fibrosarcoma line HT1080 through upregulation of integrin-mediated signaling pathways.
    Baird SK; Allan L; Renner C; Scott FE; Scott AM
    Clin Exp Metastasis; 2015 Jun; 32(5):507-16. PubMed ID: 25995078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A rare variant in human fibroblast activation protein associated with ER stress, loss of enzymatic function and loss of cell surface localisation.
    Osborne B; Yao TW; Wang XM; Chen Y; Kotan LD; Nadvi NA; Herdem M; McCaughan GW; Allen JD; Yu DM; Topaloglu AK; Gorrell MD
    Biochim Biophys Acta; 2014 Jul; 1844(7):1248-59. PubMed ID: 24717288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical implications of fibroblast activation protein in patients with colon cancer.
    Henry LR; Lee HO; Lee JS; Klein-Szanto A; Watts P; Ross EA; Chen WT; Cheng JD
    Clin Cancer Res; 2007 Mar; 13(6):1736-41. PubMed ID: 17363526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes.
    Bauer S; Jendro MC; Wadle A; Kleber S; Stenner F; Dinser R; Reich A; Faccin E; Gödde S; Dinges H; Müller-Ladner U; Renner C
    Arthritis Res Ther; 2006; 8(6):R171. PubMed ID: 17105646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
    Dienus K; Bayat A; Gilmore BF; Seifert O
    Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The carcinoma-associated fibroblast expressing fibroblast activation protein and escape from immune surveillance.
    Fearon DT
    Cancer Immunol Res; 2014 Mar; 2(3):187-93. PubMed ID: 24778314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoliposomes for Targeted Delivery of an Antifibrotic Drug.
    Schuster L; Seifert O; Vollmer S; Kontermann RE; Schlosshauer B; Hartmann H
    Mol Pharm; 2015 Sep; 12(9):3146-57. PubMed ID: 26181293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling.
    Yang X; Lin Y; Shi Y; Li B; Liu W; Yin W; Dang Y; Chu Y; Fan J; He R
    Cancer Res; 2016 Jul; 76(14):4124-35. PubMed ID: 27216177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting fibroblast activation protein in cancer - Prospects and caveats.
    Busek P; Mateu R; Zubal M; Kotackova L; Sedo A
    Front Biosci (Landmark Ed); 2018 Jun; 23(10):1933-1968. PubMed ID: 29772538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase?
    Juillerat-Jeanneret L; Tafelmeyer P; Golshayan D
    Expert Opin Ther Targets; 2017 Oct; 21(10):977-991. PubMed ID: 28829211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The road to integrative cancer therapies: emergence of a tumor-associated fibroblast protease as a potential therapeutic target in cancer.
    Puré E
    Expert Opin Ther Targets; 2009 Aug; 13(8):967-73. PubMed ID: 19606930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multi-antigen vaccine in combination with an immunotoxin targeting tumor-associated fibroblast for treating murine melanoma.
    Fang J; Hu B; Li S; Zhang C; Liu Y; Wang P
    Mol Ther Oncolytics; 2016; 3():16007. PubMed ID: 27119119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.